Clinical Trials Browser

Terminated × Neuroectodermal Tumors, Primitive × Plasma cell × Clear all

NCT02110563 2024-07-11

Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or Lymphoma

Phase 1 Terminated

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Neuroectodermal Tumors, Primitive